BioVie ( (BIVI) ) just unveiled an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
BioVie Inc. announced a direct stock offering and a private placement, aiming to raise approximately $6.66 million through the sale of shares at $1.50 each. Additionally, the company will issue warrants exercisable for shares at $1.37 per share. These funds are intended for working capital and corporate purposes, with the offering closing expected on October 22, 2024. The company is focused on developing treatments for liver and neurological diseases.
For an in-depth examination of BIVI stock, go to TipRanks’ Stock Analysis page.
